Skip to main content
Clinical Trials/NCT07693283
NCT07693283RecruitingNot Applicable

To Investigate the Expression of Target in Endometriotic Lesions

Beijing Tsinghua Chang Gung Hospital1 site in 1 country40 target enrollmentStarted: April 13, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Expression levels of molecular in endometriotic lesions and adjacent normal tissue

Study Overview

Brief Summary

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pathologically confirmed endometriosis via laparoscopy and histopathological examination
  • Complete clinical and pathological data available

Exclusion Criteria

  • History of any malignant tumor

Outcomes

Primary Outcomes

Expression levels of molecular in endometriotic lesions and adjacent normal tissue

Time Frame: 6 months

Standardized pathological histology assessment method

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lei Zhang

Principal investigator

Beijing Tsinghua Chang Gung Hospital

Study Sites (1)

Loading locations...

Similar Trials